Calidi Biotherapeutics Inc (CLDI) Stock Price, Quote & News

Company Profile

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcino...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 794 9600

Fax: 858 794 9605

Website: www.calidibio.com

Address:

4475 Executive Drive, Suite 200, San Diego, United States

uindicator Apr. 5 at 12:55 AM

$CLDI the inevitable

0 · Reply

race2zero Apr. 4 at 4:47 PM

$CLDI welcome to the shit show Scott Leftwich

0 · Reply

focafoca99 Apr. 3 at 9:04 PM

$CLDI is making a small board refresh, with Allan Camaisa not standing for re-election and the board shrinking while Scott Leftwich joins the audit committee.

0 · Reply

race2zero Apr. 2 at 9:56 PM

$CLDI sorry y’all been busy all day… I see this is still a piece of crap

0 · Reply

race2zero Apr. 2 at 9:42 PM

$CLDI again, why do you keep pumping out these pathetic pieces with the continued sad mention of CLDI? Are you part of the scam?

0 · Reply

uindicator Apr. 2 at 7:32 PM

$CLDI DAILY REMINDER THAT THIS BIOTECH IS A SCAM!! BORIS MINEV IS/WAS A FRAUD, HES CONNECTED TO OTHER FRAUDS BORIS REZNIK AND THOMAS ICHIM, THEY HAVE NEW A NEW BIOTECH SCAM CALLED IMMORTA BIO

0 · Reply

NetworkNewsWire Apr. 2 at 4:45 PM

Report Forecasts the Cancer Immunotherapy Market Hitting $311.4B by 2031 $CLDI #BioMed #Cancer https://ibn.fm/s5862

0 · Reply

MikiTrader Apr. 2 at 3:26 PM

$CLDI It hasn’t even been a month yet. At this pace, do you understand what it implies?

1 · Reply

race2zero Apr. 1 at 1:44 PM

$CLDI the 1900 bookends are right on time this morning….

0 · Reply

race2zero Apr. 1 at 1:26 PM

$CLDI this will be one of my posters I show them at the conference 🤣 I’ll be filming so we can all see their reactions to the questions I’ll throw their way. See ya soon Eric Poma 🤡

1 · Reply

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights

Mar 12, 2026, 8:00 AM EDT - 24 days ago

Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing

Mar 9, 2026, 8:50 PM EDT - 26 days ago

Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Mar 6, 2026, 8:30 AM EST - 4 weeks ago

Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering

Mar 5, 2026, 5:57 PM EST - 4 weeks ago

Calidi Biotherapeutics Announces Proposed Public Offering

Feb 20, 2026, 8:00 AM EST - 6 weeks ago

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

Feb 12, 2026, 8:00 AM EST - 7 weeks ago

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference

Nov 17, 2025, 8:00 AM EST - 4 months ago

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Nov 13, 2025, 4:15 PM EST - 5 months ago

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

Aug 21, 2025, 6:33 PM EDT - 8 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Aug 20, 2025, 9:15 AM EDT - 8 months ago

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Aug 8, 2025, 4:15 PM EDT - 8 months ago

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Jul 25, 2025, 4:45 PM EDT - 9 months ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Jul 22, 2025, 8:00 AM EDT - 9 months ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Jul 10, 2025, 8:30 AM EDT - 9 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Jul 9, 2025, 2:01 PM EDT - 9 months ago

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Jul 8, 2025, 8:30 AM EDT - 9 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Jun 27, 2025, 8:00 AM EDT - 10 months ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Apr 16, 2025, 9:30 AM EDT - 1 year ago

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

EGLE

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 28, 2025, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Feb 28, 2025, 9:00 AM EST - 1 year ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

OSTX

Feb 24, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Jan 29, 2025, 8:00 AM EST - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Jan 28, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Jan 10, 2025, 4:30 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Nov 15, 2024, 4:05 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Nov 14, 2024, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Nov 12, 2024, 5:29 PM EST - 1 year ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Oct 23, 2024, 8:31 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Oct 18, 2024, 11:00 PM EDT - 1 year ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GRRR

Aug 13, 2024, 5:37 PM EDT - 1 year ago

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Aug 2, 2024, 9:00 AM EDT - 1 year ago

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jul 29, 2024, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Jul 18, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Jul 16, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Jul 5, 2024, 4:15 PM EDT - 1 year ago

Calidi to Effect Reverse Stock Split

Jun 27, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Jun 11, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Jun 10, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

uindicator Apr. 5 at 12:55 AM

$CLDI the inevitable

0 · Reply

race2zero Apr. 4 at 4:47 PM

$CLDI welcome to the shit show Scott Leftwich

0 · Reply

focafoca99 Apr. 3 at 9:04 PM

$CLDI is making a small board refresh, with Allan Camaisa not standing for re-election and the board shrinking while Scott Leftwich joins the audit committee.

0 · Reply

race2zero Apr. 2 at 9:56 PM

$CLDI sorry y’all been busy all day… I see this is still a piece of crap

0 · Reply

race2zero Apr. 2 at 9:42 PM

$CLDI again, why do you keep pumping out these pathetic pieces with the continued sad mention of CLDI? Are you part of the scam?

0 · Reply

uindicator Apr. 2 at 7:32 PM

$CLDI DAILY REMINDER THAT THIS BIOTECH IS A SCAM!! BORIS MINEV IS/WAS A FRAUD, HES CONNECTED TO OTHER FRAUDS BORIS REZNIK AND THOMAS ICHIM, THEY HAVE NEW A NEW BIOTECH SCAM CALLED IMMORTA BIO

0 · Reply

NetworkNewsWire Apr. 2 at 4:45 PM

Report Forecasts the Cancer Immunotherapy Market Hitting $311.4B by 2031 $CLDI #BioMed #Cancer https://ibn.fm/s5862

0 · Reply

MikiTrader Apr. 2 at 3:26 PM

$CLDI It hasn’t even been a month yet. At this pace, do you understand what it implies?

1 · Reply

race2zero Apr. 1 at 1:44 PM

$CLDI the 1900 bookends are right on time this morning….

0 · Reply

race2zero Apr. 1 at 1:26 PM

$CLDI this will be one of my posters I show them at the conference 🤣 I’ll be filming so we can all see their reactions to the questions I’ll throw their way. See ya soon Eric Poma 🤡

1 · Reply

race2zero Apr. 1 at 1:18 PM

$CLDI from all accounts they will simply have a poster presentation, which almost anyone can do at these conferences. If they were legitimate they would have had an abstract accepted and be on the conference’s agenda. I’m sure it will be a lovely poster, probably the exact same one they “presented” in Los Angeles. However, you can expect they will have some very nice dinners and evenings with the 6+ million they just raised with their second round of dilution in less than 9 months 🤡🤡🤡🤡

0 · Reply

uindicator Apr. 1 at 12:41 PM

$CLDI

1 · Reply

DARKP00L Apr. 1 at 12:09 PM

$CLDI 08:03 on Apr. 01 2026 Calidi Biotherapeutics To Present New Data On Its Approach Of Simultaneously Activating T-Cells At American Association Of Cancer Research Annual Meeting #tradeideas

0 · Reply

race2zero Mar. 31 at 4:09 PM

$CLDI 1900 bid/ask bookends again…

0 · Reply

race2zero Mar. 31 at 1:44 PM

$CLDI under .20 today and once it does it isn’t coming back above. Reverse split will be announced then sub .05 at time of split, at least a 250-1 ratio, probably needs to be more like 500-1 to keep it above $1 for a few days. Good thing they have diluted so heavily to absorb the RS

0 · Reply

race2zero Mar. 30 at 7:39 PM

$CLDI why do you keep mentioning $CLDI in these AI written pieces? CLDI is complete garbage run by failed doctors and career….

0 · Reply

NetworkNewsWire Mar. 30 at 7:31 PM

Research Suggests the Thymus is Critical in Immunotherapy Outcomes $CLDI https://ibn.fm/Opf43 #tinygems #stocks

0 · Reply

race2zero Mar. 30 at 6:28 PM

$CLDI starting to sound a little repetitive, but yet another all-time low

0 · Reply

race2zero Mar. 30 at 5:39 PM

$CLDI new all-time low! Simply amazing! The reverse split is announced. This will be below five cents and the reverse split ratio is going to have to be huge.

1 · Reply

race2zero Mar. 30 at 2:00 PM

$CLDI check out all the .2801s on the tape 🤣🤣

0 · Reply

race2zero Mar. 30 at 1:31 PM

$CLDI @MikiTrader there they are right at open, they will be there all day

1 · Reply

race2zero Mar. 30 at 1:23 PM

$CLDI 10 minutes away from rhr bookend bid and ask appearing again like it has every single day for the last few weeks. If this stick wasn’t a scam penny dilution machine I’d say it’s being manipulated before the pop🤣🤣

0 · Reply

Market Cap	1.74M
Revenue (ttm)	0.00
Net Income (ttm)	-19.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.16

Volume	286,300
Avg Vol	277,882
Day's Range	N/A - N/A
Shares Out	7.37M
Stochastic %K	29%
Beta	1.42
Analysts	Strong Sell
Price Target	$10.00